Inter-assay and instrument variability of anti-Xa--results.
M J
MJ
Kovacs
M
M
Keeney
D000925:Anticoagulants / Q000627:therapeutic use; D001780:Blood Coagulation Tests / Q000295:instrumentation / Q000379:methods / Q000592:standards*; D002809:Chondroitin Sulfates / Q000494:pharmacology / Q000627:therapeutic use; D002863:Chromogenic Compounds; D017985:Dalteparin / Q000494:pharmacology / Q000627:therapeutic use; D003871:Dermatan Sulfate / Q000494:pharmacology / Q000627:therapeutic use; D004338:Drug Combinations; D016903:Drug Monitoring / Q000295:instrumentation / Q000379:methods / Q000592:standards*; D065427:Factor Xa Inhibitors; D006497:Heparan Sulfate / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D015203:Reproducibility of Results
D000925:Anticoagulants; D002809:Chondroitin Sulfates; D002863:Chromogenic Compounds; D017985:Dalteparin; D003871:Dermatan Sulfate; D004338:Drug Combinations; D065427:Factor Xa Inhibitors; D006497:Heparan Sulfate; C035838:danaparoid